Introducing Pay-for-Performance within Hong Kong’s Public Hospitals
© Lee and Gillett; licensee BioMed Central Ltd. 2010
Published: 6 October 2010
The Hong Kong Hospital Authority (HA) manages 41 publicly funded hospitals that serve approximately 90% of the seven-million population. The head office of HA is responsible for strategic planning, resources allocation, and monitoring performance of hospitals that are organized into seven geographical clusters. The head office is transforming its population-based internal resources allocation system to a Pay-for-Performance (P4P) system using case mix as a currency for strategic purchasing, as well as a performance measurement tool.
Prior to financial year 2009-10, HA allocated funding to clusters based upon a historical budget approach that was largely built upon an age-adjusted population-based model implemented in 2003-04. Hospital funding growth was curbed as a result of the poor fiscal condition of the HK government between 2003-2006. The hospital services were outdated, and there was little incentive to promote productivity and quality; hence, the waiting time was prolonged.
In 2009-10 HA introduced a new P4P hospital-funding model with budget attached to service growth in strategic priority areas such as cancer, renal dialysis, new facilities, and programmes that improve service quality and modernization. A DRG-based case-mix model was developed to measure hospital performance and to guide the hospital clusters’ baseline budget adjustment. The model was also used to allocate funding growth to strategically purchase services most needed by the community from hospital clusters, based upon the case-mix price.
Approximately HK$ 872 Mn, representing 2 – 4% of funding growth, was given to the seven hospital clusters for 2009-10. Approximately 60% was allocated for service growth, and the rest for quality and service improvement. By the end of March 2010, acute inpatient activities increased by 7.5%. There was also a dramatic increase in coded activities, with ‘coding creep’ contributing to 12% among the 20% increase in weighted episodes. The ALOS per episode was reduced by 6.7%. A ‘pay-for-quality’ incentive program is being developed for 2010/11.
This paper gives an overview of HA’s P4P and describes its impact in the first year, with substantial growth in acute admissions and DRG-weighted episodes. It outlines the difficulties and challenges encountered during implementation and discusses clinician responses to the change and the new ‘pay-for-quality’ program.
This article is published under license to BioMed Central Ltd.